Stay updated with breaking news from Cell based models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Successfully completed GLP toxicology studies for lead program GT-02287 in GBA1 Parkinson’s diseaseCompany is on track to submit application for start of Phase 1 clinical trial of GT-02287 to. | May 12, 2023 ....
Gain Therapeutics (GANX) to Present Positive Preclinical Data on its GBA1 Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Study results support the disease-modifying potential of structurally targeted allosteric regulators of GCase for the treatment of Alzheimer’s diseaseBETHESDA, Md., March 29, 2023 Gain. | March 29, 2023 ....